Inhalable Biologics Market Trends & Demand 2025-2035

Future Market Insights

Inhalable Biologics Market

Key Insight

The inhalable biologics market is expected to grow from USD 4.6 billion in 2025, and reach USD 18.9 billion by 2035, growing at a CAGR of 16.2%. Proteins and peptides will lead with a 57.8% share in 2025, while respiratory diseases will account for 62.2% revenue share in the application segment.

July 03, 2025

Anurag Sharma

250 Pages

Cite this Report

Inhalable Biologics Market

https://www.futuremarketinsights.com/reports/inhalable-biologics-market

License

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
BlackRock
Boehringer Ingelheim
CanSino Biologics
Chiesi Pharmaceuticals
F-Hoffman Roche
Kamada Pharmaceuticals
MannKind Corporation
Merxin Ltd
Teva Pharmaceutical
United Therapeutics Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Inhalable Biologics Market

Key Players

Similar Industry Reports